Acebot Cold
Composition: Aceclofenac 100 MG Paracetamol 325 MG Cetirizine 10 MG Phenylephrine HCL 5 MG Caffeine 25 MG Tablet
Packing: 10×10 Blister
Segment: G.P
MRP: ₹850
Description
Aceclofenac 100 mg + Paracetamol 325 mg + Cetirizine 10 mg + Phenylephrine 5 mg + Caffeine 25 mg Tablet is a multi-action formulation designed to provide effective relief from pain, inflammation, fever, and cold-related symptoms. This combination works synergistically to reduce body aches, headache, nasal congestion, allergic symptoms, and fatigue associated with viral infections and seasonal flu.
Manufactured in WHO-GMP certified facilities, this tablet ensures superior quality, safety, and therapeutic effectiveness. Due to its wide clinical usage, it is a high-demand product suitable for expanding pharma franchise business portfolios.
Key Benefits:
✔ Provides relief from pain and inflammation
✔ Helps reduce fever and body aches
✔ Controls allergy symptoms like sneezing and watery nose
✔ Relieves nasal congestion and sinus pressure
✔ Helps reduce fatigue and improves alertness
✔ WHO-GMP certified quality manufacturing
✔ High demand product for pharma franchise range
Composition:
- Aceclofenac 100 mg – Anti-inflammatory and pain reliever
- Paracetamol 325 mg – Antipyretic and analgesic
- Cetirizine 10 mg – Anti-allergic agent
- Phenylephrine 5 mg – Nasal decongestant
- Caffeine 25 mg – Enhances pain relief and reduces fatigue
Indications / Uses:
- Fever and viral infections
- Body pain and headache
- Sinusitis and nasal congestion
- Allergic rhinitis
- Cold and flu symptoms
Dosage Form:
- Tablets
(Dosage should be taken as directed by the physician)
Packaging:
- Blister / Alu-Alu packaging
- Customizable packing available
Pharma Franchise Opportunity:
We offer Aceclofenac Combination Tablet Pharma Franchise with:
✅ Monopoly franchise rights
✅ WHO-GMP certified manufacturing
✅ Strong promotional and marketing support
✅ High demand seasonal and general medicine product
✅ Competitive pricing and profitable margins
This product is an ideal addition to general medicine and cold & flu pharma franchise portfolios, ensuring strong market demand and repeat prescriptions.






